The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Cancer is the second leading cause of death within the US. The sooner it is detected through screening, the sooner it can be ...

Endometrial cancer is one of the most common cancers in Australian women—and one of the hardest to catch. But a new breakthrough in AI cancer detection is pushing accuracy levels to an unprecedented ...

Cancerguard by Exact Sciences is the first of its kind early detection blood test for multiple kinds of cancer. Exact Sciences is a diagnostic company focusing on early cancer detection. Cancerguard ...

SpotitEarly, a biotech startup that uses AI and dogs to detect cancer using an at-home test, announced its launch into the U.S. market with $20.3 million in funding. The company has received funding ...

For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers — allowing doctors to intervene when tumors may be easier to treat. A ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...